Concepedia

Benjamin Ortiz

BO

Statistics

Publications

56

Citations

2.3K

H-Index

27

Active since

1996

Affiliations

Novartis (United States)(Current)

University of Colorado Denver

Regeneron (United States)

Sanofi (France)

Sanofi (United States)

Benjamin Ortiz is an author at Novartis (United States) specializing in medicine, asthma, and public health.

ORCID

Top concepts

Publications per year

1996–2022

56

Publications

56

Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro et al. · The Journal of Allergy and Clinical Immunology In Practice · 2022 · 214 citations · Full text

Addressing the Childhood Asthma Crisis in Harlem: The Harlem Children’s Zone Asthma Initiative

Stephen W. Nicholas, Betina Jean-Louis, Benjamin Ortiz et al. · American Journal of Public Health · 2005 · 119 citations · Full text

The national cost of asthma among school-aged children in the United States

Patrick W. Sullivan, Vahram Ghushchyan, Prakash Navaratnam et al. · Annals of Allergy Asthma & Immunology · 2017 · 109 citations

, , +9

A Role for Autophagic Protein Beclin 1 Early in Lymphocyte Development

Ivica Arsov, Adeola Adebayo, Martina Kučerová-Levisohn et al. · The Journal of Immunology · 2011 · 107 citations · Full text

Dupilumab efficacy in chronic rhinosinusitis with nasal polyps from SINUS‐52 is unaffected by eosinophilic status

Shigeharu Fujieda, Shoji Matsune, Sachio Takeno et al. · Allergy · 2021 · 91 citations · Full text

Rows per page

1–5 of 56